Efficacy of the phosphodiesterase-4 inhibitor, apremilast, in a patient with severe alopecia areata

被引：0
|
作者：
Moe Sakakibara
Harunari Shimoyama
Mami Nomura
Chikako Nakashima
Megumi Hirabayashi
Yoshihiro Sei
Yoshihiro Kuwano
机构：
[1] Teikyo University School of Medicine,Department of Dermatology, Mizonokuchi Hospital
来源：
European Journal of Dermatology | 2019年 / 29卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：436 / 437
页数：1
相关论文
共 50 条
  • [1] Efficacy of the phosphodiesterase-4 inhibitor, apremilast, in a patient with severe alopecia areata
    Sakakibara, Moe
    Shimoyama, Harunari
    Nomura, Mami
    Nakashima, Chikako
    Hirabayashi, Megumi
    Sei, Yoshihiro
    Kuwano, Yoshihiro
    EUROPEAN JOURNAL OF DERMATOLOGY, 2019, 29 (04) : 436 - 437
  • [2] Lack of efficacy of apremilast in 9 patients with severe alopecia areata
    Liu, Lucy Y.
    King, Brett A.
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2017, 77 (04) : 773 - 774
  • [3] A Case of Pityriasis Rubra Pilaris Treated Successfully with the Phosphodiesterase-4 Inhibitor Apremilast
    Cho, Maria
    Honda, Tetsuya
    Ueshima, Chiyuki
    Kataoka, Tatsuki
    Otsuka, Atsushi
    Kabashima, Kenji
    ACTA DERMATO-VENEREOLOGICA, 2018, 98 (10) : 975 - 976
  • [4] Lack of clinical efficacy of a phosphodiesterase-4 inhibitor for treatment of heaves in horses
    Lavoie, JP
    Pasloske, K
    Joubert, P
    Cordeau, ME
    Mancini, J
    Girard, Y
    Friesen, RW
    Frenette, R
    Blouin, M
    Young, RN
    Hickey, G
    JOURNAL OF VETERINARY INTERNAL MEDICINE, 2006, 20 (01): : 175 - 181
  • [5] Efficacy and safety of apremilast, an oral phosphodiesterase 4 inhibitor, in ankylosing spondylitis
    Pathan, Ejaz
    Abraham, Sonya
    Van Rossen, Elizabeth
    Withrington, Robin
    Keat, Andrew
    Charles, Peter J.
    Paterson, Erin
    Chowdhury, Muslima
    McClinton, Catherine
    Taylor, Peter C.
    ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 (09) : 1475 - 1480
  • [6] Apremilast, a cAMP phosphodiesterase-4 inhibitor, demonstrates anti-inflammatory activity in vitro and in a model of psoriasis
    Schafer, P. H.
    Parton, A.
    Gandhi, A. K.
    Capone, L.
    Adams, M.
    Wu, L.
    Bartlett, J. B.
    Loveland, M. A.
    Gilhar, A.
    Cheung, Y-F
    Baillie, G. S.
    Houslay, M. D.
    Man, H-W
    Muller, G. W.
    Stirling, D. I.
    BRITISH JOURNAL OF PHARMACOLOGY, 2010, 159 (04) : 842 - 855
  • [7] Development of alopecia areata during phosphodiesterase 4 inhibitor treatment for psoriasis: A case report
    Peng, Chen
    Lu, Jiajing
    Yi, Xuemei
    Ding, Yangfeng
    Gao, Yunlu
    Chen, Wenjuan
    DERMATOLOGIC THERAPY, 2020, 33 (06)
  • [8] Roflumilast: A Phosphodiesterase-4 Inhibitor for the Treatment of Severe Chronic Obstructive Pulmonary Disease
    Pinner, Nathan A.
    Hamilton, Leslie A.
    Hughes, Anthony
    CLINICAL THERAPEUTICS, 2012, 34 (01) : 56 - 66
  • [9] Roflumilast - a phosphodiesterase-4 inhibitor licensed for add-on therapy in severe COPD
    Taegtmeyer, Anne B.
    Leuppi, Joerg D.
    Kullak-Ublick, Gerd A.
    SWISS MEDICAL WEEKLY, 2012, 142
  • [10] The PDE4 inhibitor, apremilast, suppresses experimentally induced alopecia areata in human skin in vivo
    Keren, Aviad
    Shemer, Avner
    Ullmann, Yehuda
    Paus, Ralf
    Gilhar, Amos
    JOURNAL OF DERMATOLOGICAL SCIENCE, 2015, 77 (01) : 74 - 76
12345